Volume 99, Issue 2

Search all International Journal of Hematology articles

February 2014

Including PIH Articles on Immunotherapy for hematological malignancies

Filter by

Volume:

Sort by

Date published:

New to old Old to new

17 articles in this issue

Professor John M. Goldman, CML Pioneer 1938–2013
Robert Peter Gale
Obituary 12 January 2014 Pages: 103 - 104
Guest editorial: immunotherapy for hematological malignancies: the quest to overcome tolerogenic drive
Norimitsu Kadowaki
Progress in Hematology 07 January 2014 Pages: 105 - 106
Peptide vaccines for hematological malignancies: a missed promise?
Monica Bocchia
Marzia Defina
Anna Sicuranza
Progress in Hematology 08 January 2014 Pages: 107 - 116
DC-based immunotherapy for hematological malignancies
Toshio Kitawaki
Progress in Hematology 31 December 2013 Pages: 117 - 122
Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors
Hiroshi Fujiwara
Progress in Hematology 19 December 2013 Pages: 123 - 131
Chimeric antigen receptor modified T cell therapy for B cell malignancies
Cameron J. Turtle
Progress in Hematology 14 December 2013 Pages: 132 - 140
Efficacy and safety of dasatinib versus imatinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP): Subset analysis of the DASISION trial with 2-year follow-up
Shin Fujisawa
Hirohisa Nakamae
Shintaro Onishi
Original Article 20 December 2013 Pages: 141 - 153
Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis
Myoung Ja Park
Manabu Sotomatsu
Yasuhide Hayashi
Original Article 14 December 2013 Pages: 154 - 161
Impact of high-dose chemotherapy and autologous transplantation as first-line therapy on the survival of high-risk diffuse large B cell lymphoma patients: a single-center study in Japan
Shojiro Inano
Makoto Iwasaki
Nobuyoshi Arima
Original Article 14 December 2013 Pages: 162 - 168
RUNX1 mutation associated with clonal evolution in relapsed pediatric acute myeloid leukemia with t(16;21)(p11;q22)
Olfat Ismael
Akira Shimada
Seiji Kojima
Original Article 28 December 2013 Pages: 169 - 174
ACE deletion polymorphism is associated with a high risk of non-infectious pulmonary complications after stem cell transplantation
Mitsuki Miyamoto
Makoto Onizuka
Kiyoshi Ando
Original Article 21 December 2013 Pages: 175 - 183
De novo mutation in DMD gene in a patient with combined hemophilia A and Duchenne muscular dystrophy
Lana Strmecki
Petra Hudler
Radovan Komel
Case Report 08 December 2013 Pages: 184 - 187
Thalidomide treatment in a myelofibrosis patient with leukemia transformation
Wei-Han Huang
Ming-Shing Li
Yi-Feng Wu
Case Report 04 December 2013 Pages: 188 - 192
Successful repeated treatment of acute myeloid leukemia in early relapse with gemtuzumab ozogamicin alone
Hiroko Tsunemine
Hiroshi Akasaka
Takayuki Takahashi
Case Report 01 December 2013 Pages: 193 - 197
MALT lymphoma of the small bowel with protein-losing enteropathy
Ayato Tsukamoto
Fumihiko Nakamura
Mineo Kurokawa
Case Report 07 January 2014 Pages: 198 - 201
inv(2)(p23q13)/RAN-binding protein 2 (RANBP2)–ALK fusion gene in myeloid leukemia that developed in an elderly woman
Yoshitomo Maesako
Kiyotaka Izumi
Hitoshi Ohno
Case Report 04 December 2013 Pages: 202 - 207
Different outcomes of allogeneic hematopoietic stem cell transplant in a pair of twins affected by juvenile myelomonocytic leukemia
Simone Cesaro
Paola De Filippi
Silvia Bresolin
Case Report 12 December 2013 Pages: 208 - 212

Volume 99, Issue 2

Professor John M. Goldman, CML Pioneer 1938–2013

Guest editorial: immunotherapy for hematological malignancies: the quest to overcome tolerogenic drive

Peptide vaccines for hematological malignancies: a missed promise?

DC-based immunotherapy for hematological malignancies

Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors

Chimeric antigen receptor modified T cell therapy for B cell malignancies

Efficacy and safety of dasatinib versus imatinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP): Subset analysis of the DASISION trial with 2-year follow-up

Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis

Impact of high-dose chemotherapy and autologous transplantation as first-line therapy on the survival of high-risk diffuse large B cell lymphoma patients: a single-center study in Japan

RUNX1 mutation associated with clonal evolution in relapsed pediatric acute myeloid leukemia with t(16;21)(p11;q22)

ACE deletion polymorphism is associated with a high risk of non-infectious pulmonary complications after stem cell transplantation

De novo mutation in DMD gene in a patient with combined hemophilia A and Duchenne muscular dystrophy

Thalidomide treatment in a myelofibrosis patient with leukemia transformation

Successful repeated treatment of acute myeloid leukemia in early relapse with gemtuzumab ozogamicin alone

MALT lymphoma of the small bowel with protein-losing enteropathy

inv(2)(p23q13)/RAN-binding protein 2 (RANBP2)–ALK fusion gene in myeloid leukemia that developed in an elderly woman

Different outcomes of allogeneic hematopoietic stem cell transplant in a pair of twins affected by juvenile myelomonocytic leukemia

Navigation